Latest Commercialization News

Audio Pixels has validated a major technical milestone for its digital MEMS speaker array and raised $1.25 million through convertible notes, while securing a $6 million funding commitment to support ongoing development amid continued ASX trading suspension.

White Energy Company Limited has bolstered its balance sheet with a $3.2 million entitlement offer while progressing multiple Australian mineral exploration projects and expanding commercial trials of its Binderless Coal Briquetting technology in South Africa.

Papyrus Australia has taken a significant step towards commercialisation with a $4.2 million supply contract and the near completion of its Adelaide Rapid Prototyping and R&D Facility.

Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.

Kairos Minerals wraps up its largest drilling campaign at Mt York, revealing promising gold zones and signing a key mining agreement with the Nyamal people, while gearing up for a resource update and further exploration.

Medallion Metals has completed a pivotal feasibility study for its Ravensthorpe Gold Project and raised $60 million to accelerate development, while progressing a key acquisition of Forrestania assets.

Impact Minerals reports significant advancements in its High Purity Alumina projects, a strategic collaboration with US battery innovator C4V, and renewed exploration activities in NSW’s Broken Hill region.

Peninsula Energy reported a $9.6 million operating cash outflow for the December 2025 quarter but maintains a strong cash position of $31.8 million, supported by a $12.6 million refinancing deal. The company anticipates uranium sales from its Lance Project to improve cash flows in coming quarters.

US1 Critical Minerals reports ongoing legal disputes over US rare earth tenements while advancing Tanzanian uranium exploration and securing $1.5 million in new capital.

OncoSil Medical has reported a record quarter for dose sales alongside key European market entries and a successful manufacturing milestone, signalling growing momentum for its pancreatic cancer treatment.

Imugene Limited has reported compelling clinical trial results for its off-the-shelf CAR T therapy, azer-cel, alongside FDA validation and a strategic collaboration, while managing cash flow amid cost reductions.

Green360 Technologies has made significant strides in commercialising its low-carbon cement product Eco-Clay, delivering successful large-scale trials and securing a robust financial footing heading into 2026.